Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Diabetic retinopathy is one of the most common microvascular complications of diabetes, affecting nearly 50% of patients with diabetes. Diabetic retinopathy can affect almost anyone with diabetes, while an additional 5.4 million have undiagnosed dia More
Novel peptides have been developed that are useful to induce Autoimmune Anterior Uveitis (AAU) and to treat symptoms associated with Anterior Uveitis. Additional potential uses for these peptides include identification of specific antigenic or uveitogeni More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2011 - 8 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 8 pages - $75
Wrigley's 5 Gum Case Study: remaining competitive in the gum market through a multi-sensory offering
Aug 2009 - 10 pages - $295
Nov 2011 - 8 pages - $75
Nov 2010 - 146 pages - $3,500
Jan 2006 - 21 pages - $1,100
Jun 2006 - 422 pages - $2,495
Your selection
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Therapeutic target
- Cataract
- Chlamydia trachomatis
- Conjunctivitis
- Corneal erosion
- Corneal ulcer
- Diabetic retinopathy
- Dry eyes
- Glaucoma
- Hyperopia
- Macular degeneration
- Ophthalmic disorder (other)
- Retinopathy
- Sight disorders
- Uveitis
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us